This inventor holds 2 USPTO granted patents. Top assignee: Lynthera Corporation. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Innovations of Jeffry Chung-Hwang Yang
Introduction
Jeffry Chung-Hwang Yang is an accomplished inventor based in York, PA (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative ocular devices. With a total of 2 patents, Yang's work is at the forefront of medical technology.
Latest Patents
Yang's latest patent focuses on a high-precision drug delivery system utilizing a dual-domain ocular device. This invention relates to a nanocomposite ocular device designed to release drugs in close proximity to the ocular surface. The device ensures controlled and sustained release of medication at a constant rate, achieving both optical and medical functions. It comprises a drug, one or more reservoir domains, and a barrier layer that blocks drug diffusion paths from the reservoir to the ocular surface. The drug partitions between the reservoir domain and the barrier layer, with the equilibrium drug solubility in the reservoir being at least five times higher than that in the barrier layer.
Career Highlights
Yang is currently associated with Lynthera Corporation, where he continues to develop innovative solutions in drug delivery. His work has garnered attention for its potential to improve patient outcomes in ocular treatments.
Collaborations
Yang collaborates with notable colleagues, including Arthur Jing-Min Yang and Roman C Domszy, who contribute to his research and development efforts.
Conclusion
Jeffry Chung-Hwang Yang's contributions to the field of drug delivery through his innovative ocular devices highlight his role as a leading inventor. His work promises to enhance the effectiveness of medical treatments and improve the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile